Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03810794Recruiting
Randomised, single-blind trial in Alzheimer's disease (AD) (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale-cognition at 12 weeks. Started Mar 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03810794.